ReviewFrontiers in endocrinology2021

Efficacy of Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Concurrent Type 2 Diabetes Mellitus and Non-Alcoholic Steatohepatitis: A Review of the Evidence.

Koichi YabikuPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.